May 2005
Volume 46, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2005
Pigment Epithelium–Derived Factor Inhibits bFGF–Induced Corneal Neovascularization in Mice
Author Affiliations & Notes
  • S.P. Herretes
    Ophthalmology, Johns Hopkins Hospital, Baltimore, MD
  • O. Suwan–apichon
    Ophthalmology, Johns Hopkins Hospital, Baltimore, MD
  • J.M. G. Reyes
    Ophthalmology, Johns Hopkins Hospital, Baltimore, MD
  • A. Pirouzmanesh
    Ophthalmology, Johns Hopkins Hospital, Baltimore, MD
  • M. Cano
    Ophthalmology, Johns Hopkins Hospital, Baltimore, MD
  • Y. Yu
    Ophthalmology, Johns Hopkins Hospital, Baltimore, MD
  • P. Gehlbach
    Ophthalmology, Johns Hopkins Hospital, Baltimore, MD
  • R.S. Chuck
    Ophthalmology, Johns Hopkins Hospital, Baltimore, MD
  • A. Behrens
    Ophthalmology, Johns Hopkins Hospital, Baltimore, MD
  • E.J. Duh
    Ophthalmology, Johns Hopkins Hospital, Baltimore, MD
  • Footnotes
    Commercial Relationships  S.P. Herretes, None; O. Suwan–apichon, None; J.M.G. Reyes, None; A. Pirouzmanesh, None; M. Cano, None; Y. Yu, None; P. Gehlbach, None; R.S. Chuck, None; A. Behrens, None; E.J. Duh, None.
  • Footnotes
    Support  RPB (Research to Prevent Blindness)
Investigative Ophthalmology & Visual Science May 2005, Vol.46, 4490. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      S.P. Herretes, O. Suwan–apichon, J.M. G. Reyes, A. Pirouzmanesh, M. Cano, Y. Yu, P. Gehlbach, R.S. Chuck, A. Behrens, E.J. Duh; Pigment Epithelium–Derived Factor Inhibits bFGF–Induced Corneal Neovascularization in Mice . Invest. Ophthalmol. Vis. Sci. 2005;46(13):4490.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: Angiogenesis is an important pathogenic process in inflammatory and immunologic conditions involving the cornea. Pigment epithelium–derived factor (PEDF) has been found to inhibit neovascularization (NV) in various tissue beds. Our objective in this study is to characterize the ability of PEDF to inhibit corneal NV induced by basic fibroblast growth factor (bFGF or FGF–2) using a corneal micropocket assay in mice. Methods: Three groups of C57BL/6 mice were surgically implanted with a hydron polymer–based pellet into a corneal micropocket, using a modification of the technique described by Kenyon et al (IOVS 1996;37:1625–32). The pellet contained either bFGF and Sucralfate (group 1, n = 10), bFGF, PEDF, and Sucralfate (group 2, n = 10), or phosphate buffered saline (PBS) and Sucralfate (control group, n = 10). On day 5 after implantation, eyes were photographed using a digital camera (Nikon Coolpix 990, Nikon Inc., Melville, NY) and a 17X macro lens. Two parameters were used to assess corneal NV: the maximal vessel length (VL) extending from the limbal vasculature towards the pellet, and the contiguous circumferential zone of NV (clock hours of NV, where 1 clock hour equals 30 degrees of arc). The area of NV was then calculated as described by Kenyon et al (Exp Eye Res 1997;64:971–8). Results: Consistent with previous observations, bFGF implantation produced a vigorous neovascular response in all eyes. Addition of PEDF to the pellet resulted in a significantly reduced area of NV when compared to bFGF alone (p<0.05). The difference in area of NV between the control and the combined PEDF/bFGF groups was not statistically significant. One mouse developed an infectious corneal ulcer and was not included in statistical analysis. Conclusions: In this mouse micropocket model, PEDF has a significant inhibitory effect on bFGF–induced corneal NV. PEDF may represent a potential treatment modality for corneal neovascular disorders. Further studies relating to alternative methods of PEDF delivery are in progress.

Keywords: neovascularization • cornea: basic science • anterior segment 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×